Trademark: 86836956
Word

Status
Registered
Status Code
700
Status Date
Tuesday, March 13, 2018
Serial Number
86836956
Registration Number
5420871
Registration Date
Tuesday, March 13, 2018
Mark Type
2000
Filing Date
Wednesday, December 2, 2015
Published for Opposition
Tuesday, June 6, 2017

Trademark Owner History
Seqirus UK Limited - Original Registrant

Classifications
5 Vaccines; medicated serums for the treatment of influenza; antibodies for medical use, namely, immunoglobulins; influenza vaccines; adjuvants for medical purposes for use with vaccines and for immunological purposes; pharmaceutical substances in the nature of antigens, namely, antigen vaccines, antigens for the treatment of influenza, and antigens for development of third party pharmaceutical and immunological products; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, or diseases caused by bacteria and viruses; blood products for medical use, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for medical therapeutic use; medicated serums, namely, anti-venoms for treatment of bites and stings; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, Rheysys Factor D Antigen reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or immunoglobulin subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes
1 Chemical and biological reagents for scientific use and/or for non-medical purposes; cell cultures and media for scientific use and/or for non-medical purposes; chemical test kits for scientific and laboratory use for anti-body screening, blood grouping or for detection of specific blood cells, antigens or immunoglobulin subtypes; chemical preparations for scientific and/or industrial purposes; diagnostic reagents for scientific use; chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells
44 Medical services; medical information services; health care services, namely, nursing services; health care information services; health care services, namely, medical services in the nature of patient support services and programs; health care services, namely, medical services in the nature of providing medical information concerning blood products, and providing medical information concerning vaccines, anti-venoms and immunohematology products in the nature of diagnostic reagents; medical services, namely, patient support services in the nature of providing medical information, including patient medical information, via an internet database, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community
The mark consists of two curved lines which partially overlap and define an opening extending downwardly to the right, one curved line being red and the other curved line being gray, and together the curved lines forming a C-shape.
The color(s) gray and red is/are claimed as a feature of the mark.

Trademark Events
Mar 13, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 25, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 25, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 18, 2018
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 18, 2018
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 13, 2018
Registered-Principal Register
Feb 5, 2018
1(B) Basis Deleted; Proceed To Registration
Jan 25, 2018
Notice Of Allowance Cancelled
Feb 5, 2018
Case Assigned To Intent To Use Paralegal
Jan 25, 2018
Teas Delete 1(B) Basis Received
Aug 1, 2017
Noa E-Mailed - Sou Required From Applicant
Jun 6, 2017
Official Gazette Publication Confirmation E-Mailed
Jun 6, 2017
Published For Opposition
May 17, 2017
Notification Of Notice Of Publication E-Mailed
May 4, 2017
Law Office Publication Review Completed
Apr 25, 2017
Approved For Pub - Principal Register
Apr 19, 2017
Teas/Email Correspondence Entered
Apr 19, 2017
Correspondence Received In Law Office
Apr 19, 2017
Teas Response To Office Action Received
Mar 14, 2017
Notification Of Non-Final Action E-Mailed
Mar 14, 2017
Non-Final Action E-Mailed
Mar 14, 2017
Non-Final Action Written
Mar 14, 2017
Non-Final Action Written
Feb 16, 2017
Teas/Email Correspondence Entered
Feb 16, 2017
Correspondence Received In Law Office
Feb 14, 2017
Teas Response To Office Action Received
Oct 21, 2016
Notification Of Non-Final Action E-Mailed
Oct 21, 2016
Non-Final Action E-Mailed
Oct 21, 2016
Non-Final Action Written
Sep 30, 2016
Teas/Email Correspondence Entered
Sep 30, 2016
Correspondence Received In Law Office
Sep 29, 2016
Assigned To Lie
Sep 15, 2016
Teas Response To Office Action Received
Jul 1, 2016
Attorney/Dom.Rep.Revoked And/Or Appointed
Jul 1, 2016
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 25, 2016
Notification Of Non-Final Action E-Mailed
Mar 25, 2016
Non-Final Action E-Mailed
Mar 25, 2016
Non-Final Action Written
Mar 21, 2016
Assigned To Examiner
Dec 8, 2015
Notice Of Design Search Code E-Mailed
Dec 7, 2015
New Application Office Supplied Data Entered
Dec 5, 2015
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24